Lets the President make deals to get more medical supplies from trusted countries.
This bill would let the President negotiate new trade agreements to make sure the U.S. has a steady supply of medical goods. These deals would aim to lower costs and diversify where we get medicines and devices, especially during emergencies. Congress would have a say in approving these new agreements.
Today, the President has general authority to enter into trade agreements, but there is no specific legal framework to eliminate duties or other import restrictions on medical goods with "trusted trade partners." Medical supply chains faced significant challenges during the COVID-19 pandemic. After this bill, the President would have specific authority to negotiate and enter into "trusted trade partner agreements" to remove duties and barriers on medical goods. This would involve specific criteria for partner selection, detailed congressional oversight, and an enforcement process, aiming for more secure and diverse medical supply chains.
HR 2213 · 119th Congress · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
23 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.